Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/7/26 16:21 | 4/2/26 | ALNY | Health | Drug | Pharmaceutical Preparations | McLaughlin Melissa | MA | O | CHRO | 1 | S.m | -1,274 | 325.92 | 0 | -4 | 9 | D | |||||||||||||||
3/6/26 16:13 | 3/4/26 | ALNY | Health | Drug | Pharmaceutical Preparations | Garg Pushkal | MA | O | EVP Chie | 5 | S.dm | -4,883 | 287.55 | 0 | -17 | 26 | D | |||||||||||||||
3/6/26 16:13 | 3/4/26 | ALNY | Health | Drug | Pharmaceutical Preparations | Greenstreet Yvonne | MA | DO | CEO | 4 | S.d | -5,333 | 235.85 | 0 | -23 | 99 | D | |||||||||||||||
3/6/26 16:12 | 3/4/26 | ALNY | Health | Drug | Pharmaceutical Preparations | Poulton Jeffrey V. | MA | O | EVP,CFO | 4 | S.d | -2,215 | 251.06 | 0 | -9 | 64 | D | |||||||||||||||
3/6/26 16:12 | 3/4/26 | ALNY | Health | Drug | Pharmaceutical Preparations | Tanguler Tolga | MA | O | EVP,Chie | 4 | S.d | -1,877 | 249.21 | 0 | -8 | 37 | D | |||||||||||||||
3/6/26 16:11 | 3/4/26 | ALNY | Health | Drug | Pharmaceutical Preparations | Fitzgerald Kevin Joseph | MA | O | CSO,EVP, | 3 | S.dm | -2,754 | 322.50 | 0 | -9 | 22 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |